American College of Preventive Medicine policy statement: Screening for skin cancer

American Journal of Preventive Medicine

Volumn 14, Issue 1, 1998, Pages 80-82

  Ferrini, Rebecca L ^a,b   Perlman, Monica ^a   Hill, Linda ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b American College of Preventive Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CANCER SURVIVAL; HEALTH CARE POLICY; HUMAN; MEDICAL SOCIETY; MELANOMA; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; REVIEW; SKIN CANCER; SKIN EXAMINATION;

EID: 0031931867     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(97)00007-X     Document Type: Article

References (23)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA: Cancer J Clin 1996;46:5-27.
2. Ries LAG, Hankey BF, Miller BA, et al. Cancer statistics review 1973-1988. Bethesda, Maryland: National Cancer Institute, 1991. NIH Report No. 91-2789.
3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA: Cancer J Clin 1997;47:5-27.
4. Rigel DS, Kopf AW, Friedman RJ. The rate of malignant melanoma in the United States: are we making an impact? J Am Acad Dermatol 1987;17:1050-3.
5. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut Tumor Registry. N Engl J Med 1986;315:1394-7.
6. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I-IV. Arch Dermatol 1988;124:869-71.
7. Graham S, Marshall J, Haughhey B, et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol 1985; 122:606-19.
8. Rigel DS, Friedman RJ, Kopf AW. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 1986;14:857-60.
9. Lee G, Massa MC, Welykyi S, et al. Yield from total skin examination and effectiveness of skin cancer awareness program. Cancer 1991;67:202-5.
10. Bolognia JL, Berwick M, Fine JA. Complete follow-up and evaluation of a skin cancer screening in Connecticut. J Am Acad Dermatol 1990;23:1098-1106.
11. Marghoob AA, Slade J, Salopek TG, et al. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Cancer 1995;75:707-14.
12. Koh HK, Cutaneous melanoma. N Engl J Med 1991;325: 171-82.
13. Rampen FHJ, Idy JAM, Velson C, et al. False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol 1995;33:59-63.
14. Koh HK, Geller AC, Miller DR, Lew RA. The early detection of and screening for melanoma. Cancer 1995; 75:674-83.
15. Herd RM, Cooper EJ, Hunter JA, et al. Cutaneous malignant melanoma: publicity, screening clinics and survival, the Edinburgh experience 1982-90. Br J Dermatol 1995; 132:563-70.
16. Tiersten AD, Grin CM, Kopf AW, et al. Prospective follow-up for malignant melanoma in patients with atypical mole (dysplastic-nevus) syndrome. J Dermatol Surg Oncol 1991;17:44-48.
17. Asri GD, Clark WH Jr., Guerry D VI, et al. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990;22:1042-8.
18. MacDonald CJ. Status of screening for skin cancer. Cancer 1993;72:1066-72.
19. Burton RC. Analysis of public education and the implications with regard to nonprogressive thin melanomas. Curr Opin Oncol 1995;7:1970-4.
20. Girgis A, Campbell EM, Redman S, Sanson-Fisher RW. Screening for melanoma: a community survey of prevalence and predictors. Med J Aust 1991;154:338-43.
21. Koh HK, Geller AC, Miller DR, et al. Who is being screened for melanoma/skin cancer? J Am Acad Dermatol 1991;24:271-7.
22. Wender RC. Barriers to effective skin cancer detection. Cancer 1995;75:691-8.
23. Cassileth BR, Clark WH, Lusk EJ, et al. How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol 1986;14:555-60.